Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Chinese Patent Office
Colorcon
UBS
QuintilesIMS
McKinsey
Harvard Business School
Dow
Cipla
Mallinckrodt

Generated: April 24, 2018

DrugPatentWatch Database Preview

MEDIHALER-EPI Drug Profile

« Back to Dashboard

Which patents cover Medihaler-epi, and when can generic versions of Medihaler-epi launch?

Medihaler-epi is a drug marketed by 3M and is included in one NDA.

The generic ingredient in MEDIHALER-EPI is epinephrine bitartrate. There are nineteen drug master file entries for this compound. Additional details are available on the epinephrine bitartrate profile page.
Drug patent expirations by year for MEDIHALER-EPI
Synonyms for MEDIHALER-EPI
(-)-3,4-dihydroxy-a-((methylamino)methyl)benzyl alcohol(+)-tartrate(1:1) salt
(-)-3,4-Dihydroxy-alpha-((methylamino)methyl)benzyl alcohol (+)-tartrate (1:1) salt
(-)-Adrenaline acid tartrate
(-)-Adrenaline bitartrate
(-)-Adrenaline hydrogen tartrate
(-)-Adrenaline tartrate
(-)-Epinephrine (+)-bitartrate
(-)-Epinephrine (+)-bitartrate salt, solid
(-)-Epinephrine (+)-bitartrate salt, tested according to Ph.Eur.
(-)-Epinephrine bitartrate
(2R,3R)-2,3-dihydroxybutanedioic acid; 4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
(2R,3R)-2,3-dihydroxybutanedioic acid;4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol
(R)-(-)-Epinephrine bitartrate
(R)-4-(1-hydroxy-2-(methylamino)ethyl)benzene-1,2-diol (2R,3R)-2,3-dihydroxysuccinate
1,2-Benzenediol, 4-(1-hydroxy-2-(methylamino)ethyl)-, (R)-, (R-(R*,R*))-2,3-dihydroxybutanedioate (1:1) (salt)
1,2-Benzenediol, 4-(1-hydroxy-2-(methylamino)ethyl)-, (theta)-, (theta-(theta,theta))-2,3-dihydroxybutanedioate (1:1) (salt)
16536-89-3
24351-82-4
30Q7KI53AK
3506-10-3
4-[(1R)-1-hydroxy-2-(methylamino)ethyl]benzene-1,2-diol, (2R,3R)-2,3-dihydroxy butanedioic acid
51-42-3
5502-52-3
8028-06-6
AB1009544
AC1L1L78
AC1Q5R39
Adrenaline acid tartrate
Adrenaline acid tartrate, l-
Adrenaline bitartrate
Adrenaline hydrogen tartrate
adrenaline tartrate
Adrenaline Tartrate (L-Adrenaline Tartrate)
Adrenaline tartrate with impurity A, European Pharmacopoeia (EP) Reference Standard
Adrenaline tartrate, European Pharmacopoeia (EP) Reference Standard
Adrenaline tatrate
Adrenalinetartrate
AKOS015951390
AN-24393
Asmatane mist (TN)
Asthmahaler
BC677071
BCP0726000242
BCP9000650
Benzyl alcohol, 3,4-dihydroxy-alpha-((methylamino)methyl)-, (-)-, tartrate (1:1), (+)-
Bronitin
Bronitin Mist
Bronkaid Mist Suspension
CAS-51-42-3
CHEMBL1200818
CS-2557
D02149
DSSTox_CID_29375
DSSTox_GSID_49415
DSSTox_RID_83490
DTXSID3049415
EINECS 200-097-1
Epinephrine acid tartrate
Epinephrine bitartrate
Epinephrine bitartrate (Adrenalinium)
Epinephrine bitartrate (JAN/USP)
Epinephrine bitartrate [USAN:JAN]
Epinephrine bitartrate [USP:JAN]
Epinephrine Bitartrate, pharmaceutical secondary standard; traceable to USP, PhEur and BP
Epinephrine bitartrate, United States Pharmacopeia (USP) Reference Standard
Epinephrine d-bitartrate
Epinephrine hydrogen tartrate
EPINEPHRINE TARTRATE
epinephrinehydrogentartrate
HY-B0447A
KB-50546
L-Adrenalin Bitartrate
l-Adrenaline bitartrate
l-Adrenaline d-bitartrate
l-Adrenaline hydrogen tartrate
L-Adrenaline tartrate
L-ADRENALINEBITARTRATE
L-Epinephrine (Bitartrate)
l-Epinephrine bitartrate
l-Epinephrine d-bitartrate
l-Epinephrine tartrate
L-tartaric acid; epinephrine
L(+)-tartaric acid; epinephrine
LS-42887
Medihaler-epi (TN)
MolPort-003-910-040
NCGC00260385-01
Primatene Mist Suspension
s2521
SCHEMBL40741
ST50409530
Tox21_202839
UNII-30Q7KI53AK

US Patents and Regulatory Information for MEDIHALER-EPI

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
3m MEDIHALER-EPI epinephrine bitartrate AEROSOL, METERED;INHALATION 010374-003 Approved Prior to Jan 1, 1982 DISCN No No ➤ Sign Up ➤ Sign Up ➤ Sign Up
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set. Subscribe for full access, or try a Free Trial

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Fuji
Baxter
McKesson
Moodys
Farmers Insurance
Daiichi Sankyo
Cantor Fitzgerald
US Department of Justice
Federal Trade Commission

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.